Overexpression of initiator methionine tRNA leads to global reprogramming of tRNA expression and increased proliferation in human epithelial cells

RNA

Volumn 19, Issue 4, 2013, Pages 461-466

  Pavon Eternod, Mariana ^a   Gomes, Suzana ^a   Rosner, Marsha R ^a   Pan, Tao ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Initiator methionine tRNA; tRNA; tRNA microarrays

Indexed keywords

METHIONINE; TRANSFER RNA;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL ACTIVITY; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MYELOMA CELL; PHENOTYPE; PRIORITY JOURNAL; STABLE TRANSFECTION; TRANSIENT TRANSFECTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; PROTEIN BIOSYNTHESIS; RNA, TRANSFER; RNA, TRANSFER, AMINO ACYL; TRANSCRIPTOME;

EID: 84875465521     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.037507.112     Document Type: Article

References (27)

1. Agris PF, Vendeix FA, Graham WD. 2007. tRNA's wobble decoding of the genome: 40 years of modification. J Mol Biol 366: 1-13.
2. Alexandrov A, Chernyakov I, GuW, Hiley SL, Hughes TR, Grayhack EJ, Phizicky EM. 2006. Rapid tRNA decay can result from lack of nonessential modifications. Mol Cell 21: 87-96.
3. Anderson J, Phan L, Cuesta R, Carlson BA, Pak M, Asano K, Bjork GR, Tamame M, Hinnebusch AG. 1998. The essential Gcd10p-Gcd14p nuclear complex is required for 1-methyladenosine modification and maturation of initiator methionyl-tRNA. Genes Dev 12: 3650-3662.
4. Bjornsti MA, Houghton PJ. 2004. Lost in translation: Dysregulation of cap-dependent translation and cancer. Cancer Cell 5: 519-523.
5. Borel F, Hartlein M, Leberman R. 1993. In vivo overexpression and purification of Escherichia coli tRNAser. FEBS Lett 324: 162-166.
6. Buvoli M, Buvoli A, Leinwand LA. 2000. Suppression of nonsense mutations in cell culture and mice by multimerized suppressor tRNA genes. Mol Cell Biol 20: 3116-3124.
7. Carbon P, Haumont E, Fournier M, de Henau S, Grosjean H. 1983. Sitedirected in vitro replacement of nucleosides in the anticodon loop of tRNA: Application to the study of structural requirements for queuine insertase activity. EMBO J 2: 1093-1097.
8. Chen W, Bocker W, Brosius J, Tiedge H. 1997a. Expression of neural BC200 RNA in human tumours. J Pathol 183: 345-351.
9. Chen W, Heierhorst J, Brosius J, Tiedge H. 1997b. Expression of neural BC1 RNA: Induction in murine tumours. Eur J Cancer 33: 288-292.
10. Dieci G, Fiorino G, Castelnuovo M, Teichmann M, Pagano A. 2007. The expanding RNA polymerase III transcriptome. Trends Genet 23: 614-622.
11. Dittmar KA, Mobley EM, Radek AJ, Pan T. 2004. Exploring the regulation of tRNA distribution on the genomic scale. J Mol Biol 337: 31-47.
12. Dittmar KA, Goodenbour JM, Pan T. 2006. Tissue-specific differences in human transfer RNA expression. PLoS Genet 2: e221.
13. Geiduschek EP, Kassavetis GA. 2001. The RNA polymerase III transcription apparatus. J Mol Biol 310: 1-26.
14. Geslain R, Cubells L, Bori-Sanz T, Alvarez-Medina R, Rossell D, Marti E, Ribas de Pouplana L. 2010. Chimeric tRNAs as tools to induce proteome damage and identify components of stress responses. Nucleic Acids Res 38: e30.
15. Kadaba S, Krueger A, Trice T, Krecic AM, Hinnebusch AG, Anderson J. 2004. Nuclear surveillance and degradation of hypomodified initiator tRNAMet in S. cerevisiae. Genes Dev 18: 1227-1240.
16. Kadaba S, Wang X, Anderson JT. 2006. Nuclear RNA surveillance in Saccharomyces cerevisiae: Trf4p-dependent polyadenylation of nascent hypomethylated tRNA and an aberrant form of 5S rRNA. RNA 12: 508-521.
17. Kohrer C, Xie L, Kellerer S, Varshney U, RajBhandary UL. 2001. Import of amber and ochre suppressor tRNAs into mammalian cells: A general approach to site-specific insertion of amino acid analogues into proteins. Proc Natl Acad Sci 98: 14310-14315.
18. Marshall L, White RJ. 2008. Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer 8: 911-914.
19. Pandolfi PP. 2004. Aberrant mRNA translation in cancer pathogenesis: An old concept revisited comes finally of age. Oncogene 23: 3134-3137.
20. Pavon-Eternod M, Gomes S, Geslain R, Dai Q, Rosner MR, Pan T. 2009. tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res 37: 7268-7280.
21. Pavon-Eternod M, Wei M, Pan T, Kleiman L. 2010. Profiling non-lysyl tRNAs in HIV-1. RNA 16: 267-273.
22. Phizicky EM, Hopper AK. 2010. tRNA biology charges to the front. Genes Dev 24: 1832-1860.
23. Sorensen MA, Elf J, Bouakaz E, Tenson T, Sanyal S, Bjork GR, Ehrenberg M. 2005. Over expression of a tRNALeu isoacceptor changes charging pattern of leucine tRNAs and reveals new codon reading. J Mol Biol 354: 16-24.
24. Vanacova S, Wolf J, Martin G, Blank D, Dettwiler S, Friedlein A, Langen H, Keith G, KellerW. 2005. A new yeast poly(A) polymerase complex involved in RNA quality control. PLoS Biol 3: e189.
25. Waas WF, Druzina Z, Hanan M, Schimmel P. 2007. Role of a tRNA base modification and its precursors in frameshifting in eukaryotes. J Biol Chem 282: 26026-26034.
26. Winter AG, Sourvinos G, Allison SJ, Tosh K, Scott PH, Spandidos DA, White RJ. 2000. RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumors. ProcNatl Acad Sci 97: 12619-12624.
27. Zhou Y, Goodenbour JM, Godley LA, Wickrema A, Pan T. 2009. High levels of tRNA abundance and alteration of tRNA charging by bortezomib in multiple myeloma. Biochem Biophys Res Commun 385: 160-164.